Skip to main content

A new category of psychotropic drugs: neuroactive lipids as exemplified by ethyl eicosapentaenoate (E-E)

  • Chapter
Progress in Drug Research

Part of the book series: Progress in Drug Research ((PDR,volume 59))

Summary

New treatments for psychiatric disorders are urgently required. Recent reviews show that there have been no improvements in efficacy of drugs for either affective disorders or schizophrenia since the first compounds were introduced over 40 years ago. Neuroactive lipids represent an entirely novel class of psychotropic compounds. Ethyl eicosapentaenoate is the first example of this group. Placebo-controlled studies have found it to be effective in depression, in treatment-unresponsive schizophrenia and in tardive dyskinesia. It is extremely well tolerated with none of the usual side-effects of either antidepressants or neuroleptics. It probably works by modulating post-receptor signal transduction processes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. A. Khan, S.R. Khan, R.M. Leventhal and W.A. Brown: Am. J. Psychiatry1581449 (2001).

    Article  PubMed  CAS  Google Scholar 

  2. S.M. Gilbody, A.M. Bagnall, L. Duggan and A. Tuunainen: Cochrane Database Syst. Rev. CD002306 (2000).

    Google Scholar 

  3. L. Duggan, M. Fenton, R.M. Dardennes, A. El-Dosoky and S. Indran: Cochrane Database Syst. Rev. CD001359 (2000).

    Google Scholar 

  4. J. Geddes, N. Freemantle, P. Harrison and P. Bebbington: BMJ3211371 (2000).

    Article  PubMed  CAS  Google Scholar 

  5. I.M. Anderson: J. Affect Disord. 58, 19–36 (2000).

    Article  PubMed  CAS  Google Scholar 

  6. P. Bech, P. Cialdella, M.C. Haugh, M.A. Birkett, A. Hours, J.P. Boissel and G.D. Tollefson: Br. J. Psychiatry176421 (2000).

    Article  PubMed  CAS  Google Scholar 

  7. A. Khan, H.A. Warner and W.A. Brown: Arch. Gen. Psychiatry 57, 311 (2000).

    Article  PubMed  CAS  Google Scholar 

  8. A. Khan, S.R. Khan, R.M. Leventhal and W.A. Brown: Int. J. Neuropsychopharmacol.4113 (2001).

    Article  PubMed  CAS  Google Scholar 

  9. C. Barbui, M. Hotopf, N. Freemantle, J. Boynton, R. Churchill, M.P. Eccles, J.R. Geddes, R. Hardy, G. Lewis and J.M. Mason: Cochrane Database Syst. Rev.4CD002791 (2000).

    PubMed  Google Scholar 

  10. W. Sneader: Drug discovery: The evolution of modern medicine, Wiley, Chichester 1985.

    Google Scholar 

  11. D. Healy: The antidepressant era, Harvard University Press, Cambridge 1997.

    Google Scholar 

  12. C. Holden: Science29429 (2001).

    Article  PubMed  CAS  Google Scholar 

  13. J.H. Austin: Chase, chance and creativity: the lucky art of novelty, Columbia University Press, New York 1985.

    Google Scholar 

  14. J. Thullier: Ten years that changed the face of mental illness, Martin Dunitz, London 1999.

    Google Scholar 

  15. D.F. Horrobin: J. R. Soc. Medicine93341 (2000).

    CAS  Google Scholar 

  16. D.F. Horrobin: Nat. Biotechnol.191099 (2001).

    Article  PubMed  CAS  Google Scholar 

  17. F. Hirata and J. Axelrod: Science2091082 (1980).

    Article  PubMed  CAS  Google Scholar 

  18. Y. Tsegaye, K.O. Daasvatn and H. Holmsen: Platelets1331 (2002).

    Article  PubMed  CAS  Google Scholar 

  19. M. Motoyoshi, M. Sugiyama, Y. Atomi, W. Kimura and H. Nagawa: Intern. J. Pancreatology2969 (2001).

    Article  CAS  Google Scholar 

  20. P. Dieter, A. Kolada, S. Kamionka, A. Schadow and M. Kaszkin: Cell Signal14199 (2002).

    Article  PubMed  CAS  Google Scholar 

  21. V. Van Putten, Z. Refaat, C. Dessev, S. Blaine, M. Wick, L. Butterfield, S.Y. Han, L.E. Heasley and R.A. Nemenoff: J. Biol. Chem.2761226 (2001).

    Article  PubMed  Google Scholar 

  22. M. Hernandez, Y. Bayon, M. Sanchez Crespo and M.L. Nieto: J. Neurochem. 73, 1641 (1999).

    Article  PubMed  CAS  Google Scholar 

  23. J. Balsinde, M.A. Balboa and E.A. Dennis: Proc. Natl. Acad. Sci. USA957951 (1998).

    Article  PubMed  CAS  Google Scholar 

  24. M. Murakami, T. Kambe, S. Shimbara and I. Kudo: J. Biol. Chem.2743103 (1999).

    Article  PubMed  CAS  Google Scholar 

  25. J. Ishiguro, T. Tada, T. Ogihara, N. Ohzawa, K. Murakami and H. Kosuzume: J. Pharmacobiodyn.11251 (1988).

    Article  PubMed  CAS  Google Scholar 

  26. H.E. Krokan, K.S. Bjerve and E. Mork: Biochim. Biophys. Acta116859 (1993).

    Article  PubMed  CAS  Google Scholar 

  27. D.F. Horrobin and C.N. Bennett: Prostaglandins Leukot. Essent. Fatty Acids60141 (1999).

    Article  PubMed  CAS  Google Scholar 

  28. C.N. Bennett and D.F. Horrobin: Prostaglandins Leukot. Essent. Fatty Acids6347 (2000).

    Article  PubMed  CAS  Google Scholar 

  29. D.F. Horrobin: Human Psychopharmacol.1645 (2001).

    Article  CAS  Google Scholar 

  30. I. Meloni, M. Muscettola, M. Raynaud, I. Longo, M. Bruttini, M.P. Moizard, M. Gomot, J. Chelly, V. des Portes, J.P. Fryns et al.: Nat. Genet. DOI: 10.1038/ng857 (2002).

    Google Scholar 

  31. E. Rassart, A. Bedirian, S. Do Carmo, O. Guinard, J. Sirois, L. Terrisse and R. Milne: Biochim. Biophys. Acta1482185 (2000).

    Article  PubMed  CAS  Google Scholar 

  32. E.A. Thomas, B. Dean, G. Pavey and J.G. Sutcliffe: Proc. Natl. Acad. Sci. USA984066 (2001).

    Article  PubMed  CAS  Google Scholar 

  33. M. Vogt and A. Skerra: J. Mol. Recognit.1479 (2001).

    Article  PubMed  CAS  Google Scholar 

  34. M.R. Witt, S.E. WesthHansen, P.B. Rasmussen, S. Hastrup and M. Nielsen: J. Neurochem.672141 (1996).

    Article  PubMed  CAS  Google Scholar 

  35. M.R. Witt and M. Nielsen: J. Neurochem.621432 (1994).

    Article  PubMed  CAS  Google Scholar 

  36. C.B. Bouzat and F.J. Barrantes: Receptors Channels1251 (1993).

    PubMed  CAS  Google Scholar 

  37. S.S. Antollini and F.J. Barrantes: J. Biol. Chem.2771249 (2002).

    Article  PubMed  CAS  Google Scholar 

  38. A.A. Farooqui and L.A. Horrocks: Brain Res. Rev.16171 (1991).

    Article  PubMed  CAS  Google Scholar 

  39. J.W. Lazarewicz, E. Salinska and J.T. Wroblewski: Adv. Exp. Med. Biol.31873 (1992).

    Article  PubMed  CAS  Google Scholar 

  40. D. Piomelli, C. Pilon, B. Giros, P. Sokoloff, M.P. Martres and J.C. Schwartz: Nature 353, 164 (1991).

    Article  PubMed  CAS  Google Scholar 

  41. H.E. Xu, M.H. Lambert, V.G. Montana, D.J. Parks, S.G. Blanchard, P.J. Brown, D.D. Sternbach, J.M. Lehmann, G.B. Wisely, T.M. Willson et al.: Mol. Cell 3, 397 (1999).

    Article  PubMed  CAS  Google Scholar 

  42. A. Leaf and J.X. Kang: World Rev. Nutr. Diet8324 (1998).

    Article  PubMed  CAS  Google Scholar 

  43. J.X. Kang and A. Leaf: Am. J. Clin. Nutr.71202S (2000).

    PubMed  CAS  Google Scholar 

  44. S.S. Palakurthi, R. Fluckiger, H. Aktas, A.K. Changolkar, A. Shahsafaei, S. Harneit, E. Kilic and J.A. Halperin: Cancer Res.602919 (2000).

    PubMed  CAS  Google Scholar 

  45. L.C. Chiu, V.E. Ooi and J.M. Wan: Int. J. Oncol.19845 (2001).

    PubMed  CAS  Google Scholar 

  46. M.J. Finnen and C.R. Lovell: Biochem. Soc. Trans.1991S (1991).

    PubMed  CAS  Google Scholar 

  47. M. Peet, D.F. Horrobin and EPA Multicentre Study Group: J. Psychiatric Res.367 (2002).

    Article  Google Scholar 

  48. M. Peet, D.F. Horrobin and E-E Multicentre Study Group: Arch. Gen. Psychiatryin press(2002).

    Google Scholar 

  49. B. Nemets, Z. Stahl and R.H. Belmaker: Am. J. Psychiatry159477 (2002).

    Article  PubMed  Google Scholar 

  50. US Food and Drug Administration, Dept of Health and Human Services: Fed. Regist.6230751 (1997).

    Google Scholar 

  51. Y. Shibutani, M. Kurokawa, K. Inoue, Y. Hamada and G. Yajima: Iyakuhin Kenkyu20826 (1989).

    CAS  Google Scholar 

  52. C.P. Burns, S. Halabi, G.H. Clamon, V. Hars, B.A. Wagner, R.J. Hohl, E. Lester, J.J. Kirshner, V. Vinciguerra and E. Paskett: Clin. Cancer Res.53942 (1999).

    PubMed  CAS  Google Scholar 

  53. J.R. Hibbeln: Lancet3511213 (1998).

    Article  PubMed  CAS  Google Scholar 

  54. J.R. Hibbeln, in: M. Peet, I. Glen and D.F. Horrobin (eds.): Phospholipid spectrum disorder in psychiatry, Marius Press, Carnforth 1999, 195–210.

    Google Scholar 

  55. J.R. Hibbeln and N. Salem Jr.: Am. J. Clin. Nutr.621 (1995).

    PubMed  CAS  Google Scholar 

  56. D.F. Horrobin: Schizophr. Res.53154 (2002).

    Google Scholar 

  57. P.B. Adams, S. Lawson, A. Sanigorski and A.J. Sinclair: Lipids31S157 (1996).

    Article  PubMed  CAS  Google Scholar 

  58. M. Maes, A. Christophe, J. Delanghe, C. Altamura, H. Neels and H.Y. Meltzer: Psychiatry Res.85275 (1999).

    Article  PubMed  CAS  Google Scholar 

  59. M. Maes, R. Smith, A. Christophe, P. Cosyns, R. Desnyder and H. Meltzer: J. Affect. Disord.3835 (1996).

    Article  PubMed  CAS  Google Scholar 

  60. C. Seko: Jpn. J. Hyg.52539 (1997).

    Google Scholar 

  61. M. Peet, B. Murphy, J. Shay and D. Horrobin: Biol. Psychiatry43315 (1998).

    Article  PubMed  CAS  Google Scholar 

  62. R. Edwards, M. Peet, J. Shay and D. Horrobin: J. Affect. Disord. 48, 149 (1998).

    Article  PubMed  CAS  Google Scholar 

  63. J. Lieb, R. Karmali and D. F. Horrobin: Prostaglandins Leukot. Med.10361 (1983).

    Article  PubMed  CAS  Google Scholar 

  64. J.R. Calabrese, R.G. Skwerer, B. Barna, D. Gulledge, R. Valenzuela, A. Butkus, S. Subichin and N.E. Krupp: Psychiatry Res.1741 (1986).

    Article  PubMed  CAS  Google Scholar 

  65. K. Ohishi, R. Ueno, S. Nishino, T. Sakai and O. Hayaishi: Biol. Psychiatry23326 (1988).

    Article  PubMed  CAS  Google Scholar 

  66. S. Nishino, R. Ueno, K. Ohishi, T. Sakai and O. Hayaishi: Am. J. Psychiatry146365 (1989).

    PubMed  CAS  Google Scholar 

  67. M. Linnoila, A.R. Whorton, D.R. Rubinow, R.W. Cowdry, P.T. Ninan and R.N. Waters: Arch. Gen. Psychiatry40405 (1983).

    Article  PubMed  CAS  Google Scholar 

  68. R.M. Carney, M.W. Rich, A. teVelde, J. Saini, K. Clark and K.E. Freedland: J. Psychosom. Res.32159 (1988).

    Article  PubMed  CAS  Google Scholar 

  69. R. Krittayaphong, W.E. Cascio, K.C. Light, D. Sheffield, R.N. Golden, J.B. Finkel, G. Glekas, G.G. Koch and D.S. Sheps: Psychosom. Med.59231 (1997).

    PubMed  CAS  Google Scholar 

  70. J.H. Christensen, P. Gustenhoff, E. Korup, J. Aaroe, E. Toft, J. Moller, K. Rasmussen, J. Dyerberg and E.B. Schmidt: Br. Med. J.312677 (1996).

    Article  CAS  Google Scholar 

  71. M.L. Burr, A.M. Fehily, J.F. Gilbert, S. Rogers, R.M. Holliday, P.M. Sweetnam, P.C. Elwood and N.M. Deadman: Lancet2757 (1989).

    Article  PubMed  CAS  Google Scholar 

  72. R.B. Singh, M.A. Niaz, J.P. Sharma, R. Kumar, V. Rastogi and M. Moshiri: Cardiovasc. Drugs Ther.11485 (1997).

    Article  PubMed  CAS  Google Scholar 

  73. Gruppo Italiano per to Studio della Streptochinasi nell’Infarto Miocardico (GISSI): Lancet 354, 447 (1999).

    Article  Google Scholar 

  74. S. Endres, R. Ghorbani, V.E. Kelley, K. Georgilis, G. Lonnemann, J.W.M. vanderMeer, J.G. Cannon, T.S. Rogers, M.S. Klempner, P.C. Weber et al.: N. Engl. J. Med.320265 (1989).

    Article  PubMed  CAS  Google Scholar 

  75. P. Purasiri, A. McKechnie, S.D. Heys and O. Eremin: Immunology92166 (1997).

    Article  PubMed  CAS  Google Scholar 

  76. D.F. Horrobin, in: E. Chiu, D. Ames and C. Katona (eds.): Vascular disease and affective disorders, Martin Dunitz, London 2002, 75–94.

    Google Scholar 

  77. A. Coppen and J. Bailey: J. Affect. Disord.60121 (2000).

    Article  PubMed  CAS  Google Scholar 

  78. B.K. Puri, S.J. Counsell, A.J. Richardson and D.F. Horrobin: Arch. Gen. Psychiatry5991 (2002).

    Article  PubMed  Google Scholar 

  79. M.P. Freeman: Ann. Clin. Psychiatry12159 (2000).

    PubMed  CAS  Google Scholar 

  80. M. Peet, I. Glen and D.F. Horrobin (eds.): Phospholipid spectrum disorder in psychiatry, Marius Press, Carnforth 1999.

    Google Scholar 

  81. D.F. Horrobin: Postgrad. Med. J.53(Suppl. 4), 160 (1977).

    PubMed  CAS  Google Scholar 

  82. D.F. Horrobin: Schizophr. Res.29102 (1998).

    Article  Google Scholar 

  83. D.F. Horrobin, A.I. Glen and K. Vaddadi: Schizophr. Res.13195 (1994).

    Article  PubMed  CAS  Google Scholar 

  84. D.F. Horrobin: J. Orthomolecular Psychiatry933 (1980).

    Google Scholar 

  85. P. Ward, J. Sutherland, E. Glen, A.I.M. Glen and D.F. Horrobin: Schizophr. Res.2470 (1997).

    Article  Google Scholar 

  86. C.J. Hudson, A. Lin, S. Cogan, F. Cashman and J.J. Warsh: Biol. Psychiatry41507 (1997).

    Article  PubMed  CAS  Google Scholar 

  87. G.E. Berger, H.P. Yuen and P.D. McGorry: Schizophr. Res.53538 (2002).

    Google Scholar 

  88. R. Reddy and J.K. Yao, in: M. Peet, I. Glen and D.F. Horrobin (eds.): Phospholipid spectrum disorder in psychiatry, Marius Press, Carnforth 1999, 75–88.

    Google Scholar 

  89. S.P. Mahadik, S. Sitasawad and M. Mulchandani, in: M. Peet, I. Glen and D.F. Horrobin (eds.): Phospholipid spectrum disorder in psychiatry, Marius Press, Carnforth 1999, 99–111.

    Google Scholar 

  90. J.K. Yao, R.D. Reddy, J.W. Pettegrew, D.P. vanKammen, D.F. Horrobin and S.P. Mahadik: Biol. Psychiatry4758S (2000).

    Article  Google Scholar 

  91. J.W. Pettegrew, M.S. Keshavan, K. Panchalingam, S. Strychor, D.B. Kaplan, M.G. Tretta and M. Allen: Arch. Gen. Psychiatry48563 (1991).

    Article  PubMed  CAS  Google Scholar 

  92. P. Williamson, D. Drost, J. Stanley, T. Carr, S. Morrison and H. Merskey: Arch. Gen. Psychiatry48578 (1991).

    Article  PubMed  CAS  Google Scholar 

  93. L. Demisch, H. Gerbaldo, P. Gebhart, K. Georgi and H.J. Bochnik: Psychiatry Res.22275 (1987).

    Article  PubMed  CAS  Google Scholar 

  94. J.K. Yao, D.P. van Kammen and J.A. Gurklis: Psychiatry Res.6011 (1996).

    Article  PubMed  CAS  Google Scholar 

  95. K.S. Vaddadi, P. Courtney, C.J. Gilleard, M.S. Manku and D.F. Horrobin: Psychiatry Res.27313 (1989).

    Article  PubMed  CAS  Google Scholar 

  96. M. Peet, J. Laugharne, N. Rangarajan, D.F. Horrobin and G. Reynolds: J. Psychiatr. Res.29227 (1995).

    Article  PubMed  CAS  Google Scholar 

  97. J.E. Mellor, J.D.E. Laugharne and M. Peet: Schizophr. Res.1885 (1995).

    Article  PubMed  CAS  Google Scholar 

  98. A. Nilsson, D.F. Horrobin, A. Rosengren, L. Waller, A. Adlerberth and L. Wilhelmsen: Prostaglandins Leukot. Essent. Fatty Acids5583 (1996).

    Article  PubMed  CAS  Google Scholar 

  99. R. Reddy, J.K. Yao, M. Zeigler and M.S. Keshavan: Schizophr. Res.36108 (1999).

    Google Scholar 

  100. S.P. Mahadik and R.E. Scheffer: Prostaglandins Leukot. Essent. Fatty Acids5545 (1996).

    Article  PubMed  CAS  Google Scholar 

  101. M. Peet, J. Brind, C.N. Ramchand, S. Shah and G.K. Vankar: Schizophr. Res.49243 (2001).

    Article  PubMed  CAS  Google Scholar 

  102. M. Peet and J. Mellor: Schizophr. Res.29160 (1998).

    Article  Google Scholar 

  103. D.F. Horrobin, K. Jenkins, C.N. Bennett and W.W. Christie: Prostaglandins Leukot. Essent. Fatty Acidsin press.

    Google Scholar 

  104. R.A. Emsley, C.C. Myburgh, P.P. Oosthuizen and S.J. vanRensburg: Schizophr. Res. 53, 9 (2002).

    Google Scholar 

  105. W.S. Fenton, F. Dickerson, J. Boronow, J.R. Hibbeln and M. Knable: Am. J. Psychiatry1582071 (2001).

    Article  PubMed  CAS  Google Scholar 

  106. A.L. Stoll, W.E. Severus, M.P. Freeman, S. Rueter, H.A. Zboyan, E. Diamond, K.K. Cress and L.B. Marangell: Arch. Gen. Psychiatry56407 (1999).

    Article  PubMed  CAS  Google Scholar 

  107. D.F. Horrobin and M.S. Manku: Br. Med. J.2801363 (1980).

    Article  PubMed  CAS  Google Scholar 

  108. M.C.J. Chang and C.R. Jones: Neurochem. Res.23887 (1998).

    Article  PubMed  CAS  Google Scholar 

  109. F. Bosetti, J. Rintala, R. Seeman, T.A. Rosenburger, M.A. Conteras, S.I. Rapoport and M.C. Chang: Mol. Psychiatryin press(2002).

    Google Scholar 

  110. B.M. McGahon, D.S.D. Martin, D.F. Horrobin and M.A. Lynch: Neuroscience94305 (1999).

    Article  PubMed  CAS  Google Scholar 

  111. J.J. Clifford, J. Drago, A.L. Natoli, J.Y.F. Wong, A. Kinsella, J.L. Waddington and K.S. Vaddadi: Neuroscience10981 (2002).

    Article  PubMed  CAS  Google Scholar 

  112. K.S. Vaddadi, E. Soosai, E. Chiu and P. Dingjan: Neuroreport1329 (2002).

    Article  PubMed  CAS  Google Scholar 

  113. B.K. Puri, G.M. Bydder, S.J. Counsell, B.J. Corridan, A.J. Richardson, J.V. Hajnal, C. Appel, H.M. McKee, K.S. Vaddadi and D.F. Horrobin: Neuroreport13123 (2002).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Basel AG

About this chapter

Cite this chapter

Horrobin, D.F. (2002). A new category of psychotropic drugs: neuroactive lipids as exemplified by ethyl eicosapentaenoate (E-E). In: Jucker, E. (eds) Progress in Drug Research. Progress in Drug Research, vol 59. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8171-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8171-5_6

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9464-7

  • Online ISBN: 978-3-0348-8171-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics